[go: up one dir, main page]

DE60104288D1 - Antivirale therapie - Google Patents

Antivirale therapie

Info

Publication number
DE60104288D1
DE60104288D1 DE60104288T DE60104288T DE60104288D1 DE 60104288 D1 DE60104288 D1 DE 60104288D1 DE 60104288 T DE60104288 T DE 60104288T DE 60104288 T DE60104288 T DE 60104288T DE 60104288 D1 DE60104288 D1 DE 60104288D1
Authority
DE
Germany
Prior art keywords
antiviral therapy
antiviral
hydrate
compounds
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60104288T
Other languages
English (en)
Other versions
DE60104288T2 (de
Inventor
Servatius Nottet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitair Medisch Centrum Utrecht
Universiteit Utrecht
Original Assignee
Rijksuniversiteit Utrecht
Universitair Medisch Centrum Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniversiteit Utrecht, Universitair Medisch Centrum Utrecht filed Critical Rijksuniversiteit Utrecht
Application granted granted Critical
Publication of DE60104288D1 publication Critical patent/DE60104288D1/de
Publication of DE60104288T2 publication Critical patent/DE60104288T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60104288T 2000-03-17 2001-03-19 Antivirale therapie Expired - Fee Related DE60104288T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200991 2000-03-17
EP00200991 2000-03-17
PCT/NL2001/000222 WO2001068086A1 (en) 2000-03-17 2001-03-19 Antiviral therapy

Publications (2)

Publication Number Publication Date
DE60104288D1 true DE60104288D1 (de) 2004-08-19
DE60104288T2 DE60104288T2 (de) 2005-08-25

Family

ID=8171222

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60104288T Expired - Fee Related DE60104288T2 (de) 2000-03-17 2001-03-19 Antivirale therapie

Country Status (6)

Country Link
EP (1) EP1263429B1 (de)
AT (1) ATE270886T1 (de)
AU (1) AU4485101A (de)
CA (1) CA2403358A1 (de)
DE (1) DE60104288T2 (de)
WO (1) WO2001068086A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452605A1 (de) * 2003-02-27 2004-09-01 Universiteit Utrecht Holding B.V. Verfahren zum Nachweis von antiviraler Aktivität

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973191A (en) * 1996-12-30 1999-10-26 Vanderbilt University Selective inhibitors of prostaglandin endoperoxide synthase-2
WO1999030721A1 (en) * 1997-12-17 1999-06-24 Cornell Research Foundation, Inc. Cyclooxygenase-2 inhibition
JP2002515891A (ja) * 1997-12-19 2002-05-28 スミスクライン・ビーチャム・コーポレイション 新規なピペリジン含有化合物
EP1064940A1 (de) * 1999-07-02 2001-01-03 Universitair Medisch Centrum Utrecht Antivirale Therapie

Also Published As

Publication number Publication date
CA2403358A1 (en) 2001-09-20
WO2001068086A1 (en) 2001-09-20
ATE270886T1 (de) 2004-07-15
EP1263429B1 (de) 2004-07-14
AU4485101A (en) 2001-09-24
DE60104288T2 (de) 2005-08-25
EP1263429A1 (de) 2002-12-11

Similar Documents

Publication Publication Date Title
MXPA03005464A (es) Agentes antivirales.
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
MY146279A (en) Compounds affecting glucokinase
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
SE0100568D0 (sv) Compounds
GB0112348D0 (en) Compounds
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
GB9914486D0 (en) Medicaments
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
BR0316771A (pt) Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
SE0202429D0 (sv) Novel Compounds
SE0100569D0 (sv) New compounds
SE9901573D0 (sv) New compounds
SE0102440D0 (sv) New compound
GB0130677D0 (en) Medicaments and novel compounds
SE0100566D0 (sv) Compounds
IL150817A0 (en) Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
SE0002476D0 (sv) New compounds
MXPA04005809A (es) Inhibidores de proteinas quinasas.
NO20044531L (no) Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom
SE0102057D0 (sv) New Salts I

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee